Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)

J. D. Eason, T. A. Gonwa, C. L. Davis, R. S. Sung, D. Gerber, R. D. Bloom

Research output: Contribution to journalArticle

231 Citations (Scopus)

Abstract

A consensus conference sponsored by the American Society of Transplant Surgeons (ASTS), American Society of Transplantation (AST), United Network for Organ Sharing (UNOS) and American Society of Nephrology (ASN) convened to examine simultaneous liver-kidney transplantation (SLK). Directors from the 25 largest liver transplant programs along with speakers with recognized expertise attended. The purposes of this conference were to propose indications for SLK, to establish a prospective data registry and, most importantly, to recommend standard listing criteria for these patients. Scientific registry of transplant recipients data, and single center data regarding chronic kidney disease (CKD) and acute kidney injury (AKI) in conjunction with liver failure as a basis for SLK was presented and discussed. The consensus was that Regional Review Boards (RRB) should determine listing for SLK, as with other MELD exceptions, with automatic approval for: (i) End-stage renal disease with cirrhosis and symptomatic portal hypertension or hepatic vein wedge pressure gradient ≥ 10 mm Hg (ii) Liver failure and CKD with GFR ≤ 30 mL/min (iii) AKI or hepatorenal syndrome with creatinine ≥ 2.0 mg/dL and dialysis ≥ 8 weeks (iv) Liver failure and CKD and biopsy demonstrating > 30% glomerulosclerosis or 30% fibrosis. The RRB would evaluate all other requests to determine appropriateness.

Original languageEnglish (US)
Pages (from-to)2243-2251
Number of pages9
JournalAmerican Journal of Transplantation
Volume8
Issue number11
DOIs
StatePublished - Nov 2008

Fingerprint

Liver Transplantation
Kidney Transplantation
Liver Failure
Chronic Renal Insufficiency
Acute Kidney Injury
Registries
Fibrosis
Hepatorenal Syndrome
Pulmonary Wedge Pressure
Hepatic Veins
Portal Hypertension
Portal Vein
Chronic Kidney Failure
Dialysis
Creatinine
Transplants
Biopsy
Liver

Keywords

  • Combined transplants
  • Kidney transplantation
  • Liver transplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). / Eason, J. D.; Gonwa, T. A.; Davis, C. L.; Sung, R. S.; Gerber, D.; Bloom, R. D.

In: American Journal of Transplantation, Vol. 8, No. 11, 11.2008, p. 2243-2251.

Research output: Contribution to journalArticle

Eason, J. D. ; Gonwa, T. A. ; Davis, C. L. ; Sung, R. S. ; Gerber, D. ; Bloom, R. D. / Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). In: American Journal of Transplantation. 2008 ; Vol. 8, No. 11. pp. 2243-2251.
@article{b91cc6f28b804623b06d5a3e8f6a98e0,
title = "Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)",
abstract = "A consensus conference sponsored by the American Society of Transplant Surgeons (ASTS), American Society of Transplantation (AST), United Network for Organ Sharing (UNOS) and American Society of Nephrology (ASN) convened to examine simultaneous liver-kidney transplantation (SLK). Directors from the 25 largest liver transplant programs along with speakers with recognized expertise attended. The purposes of this conference were to propose indications for SLK, to establish a prospective data registry and, most importantly, to recommend standard listing criteria for these patients. Scientific registry of transplant recipients data, and single center data regarding chronic kidney disease (CKD) and acute kidney injury (AKI) in conjunction with liver failure as a basis for SLK was presented and discussed. The consensus was that Regional Review Boards (RRB) should determine listing for SLK, as with other MELD exceptions, with automatic approval for: (i) End-stage renal disease with cirrhosis and symptomatic portal hypertension or hepatic vein wedge pressure gradient ≥ 10 mm Hg (ii) Liver failure and CKD with GFR ≤ 30 mL/min (iii) AKI or hepatorenal syndrome with creatinine ≥ 2.0 mg/dL and dialysis ≥ 8 weeks (iv) Liver failure and CKD and biopsy demonstrating > 30{\%} glomerulosclerosis or 30{\%} fibrosis. The RRB would evaluate all other requests to determine appropriateness.",
keywords = "Combined transplants, Kidney transplantation, Liver transplantation",
author = "Eason, {J. D.} and Gonwa, {T. A.} and Davis, {C. L.} and Sung, {R. S.} and D. Gerber and Bloom, {R. D.}",
year = "2008",
month = "11",
doi = "10.1111/j.1600-6143.2008.02416.x",
language = "English (US)",
volume = "8",
pages = "2243--2251",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)

AU - Eason, J. D.

AU - Gonwa, T. A.

AU - Davis, C. L.

AU - Sung, R. S.

AU - Gerber, D.

AU - Bloom, R. D.

PY - 2008/11

Y1 - 2008/11

N2 - A consensus conference sponsored by the American Society of Transplant Surgeons (ASTS), American Society of Transplantation (AST), United Network for Organ Sharing (UNOS) and American Society of Nephrology (ASN) convened to examine simultaneous liver-kidney transplantation (SLK). Directors from the 25 largest liver transplant programs along with speakers with recognized expertise attended. The purposes of this conference were to propose indications for SLK, to establish a prospective data registry and, most importantly, to recommend standard listing criteria for these patients. Scientific registry of transplant recipients data, and single center data regarding chronic kidney disease (CKD) and acute kidney injury (AKI) in conjunction with liver failure as a basis for SLK was presented and discussed. The consensus was that Regional Review Boards (RRB) should determine listing for SLK, as with other MELD exceptions, with automatic approval for: (i) End-stage renal disease with cirrhosis and symptomatic portal hypertension or hepatic vein wedge pressure gradient ≥ 10 mm Hg (ii) Liver failure and CKD with GFR ≤ 30 mL/min (iii) AKI or hepatorenal syndrome with creatinine ≥ 2.0 mg/dL and dialysis ≥ 8 weeks (iv) Liver failure and CKD and biopsy demonstrating > 30% glomerulosclerosis or 30% fibrosis. The RRB would evaluate all other requests to determine appropriateness.

AB - A consensus conference sponsored by the American Society of Transplant Surgeons (ASTS), American Society of Transplantation (AST), United Network for Organ Sharing (UNOS) and American Society of Nephrology (ASN) convened to examine simultaneous liver-kidney transplantation (SLK). Directors from the 25 largest liver transplant programs along with speakers with recognized expertise attended. The purposes of this conference were to propose indications for SLK, to establish a prospective data registry and, most importantly, to recommend standard listing criteria for these patients. Scientific registry of transplant recipients data, and single center data regarding chronic kidney disease (CKD) and acute kidney injury (AKI) in conjunction with liver failure as a basis for SLK was presented and discussed. The consensus was that Regional Review Boards (RRB) should determine listing for SLK, as with other MELD exceptions, with automatic approval for: (i) End-stage renal disease with cirrhosis and symptomatic portal hypertension or hepatic vein wedge pressure gradient ≥ 10 mm Hg (ii) Liver failure and CKD with GFR ≤ 30 mL/min (iii) AKI or hepatorenal syndrome with creatinine ≥ 2.0 mg/dL and dialysis ≥ 8 weeks (iv) Liver failure and CKD and biopsy demonstrating > 30% glomerulosclerosis or 30% fibrosis. The RRB would evaluate all other requests to determine appropriateness.

KW - Combined transplants

KW - Kidney transplantation

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=53749099347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53749099347&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2008.02416.x

DO - 10.1111/j.1600-6143.2008.02416.x

M3 - Article

C2 - 18808402

AN - SCOPUS:53749099347

VL - 8

SP - 2243

EP - 2251

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 11

ER -